Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Welcome to the last day of tax-loss selling ...

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 28, 2022 3:11pm

183 Views

Post# 35194144

RE:RE:Welcome to the last day of tax-loss selling ...

Duster340 wrote:
MrMugsy wrote: Last day of tax-loss selling ... if I have it right.

Fishing derby day !!!!!
Got mine at 44.
Can anyone claim they snagged a seller at a lower price today ?

Good luck to all contestants !!!!

you overpaid 43.5 is now on the ask lol